What should you know about stage three lung cancer?

Stage three is a broad group rather than one identical situation. The tumour may be close to important chest structures, or cancer may be present in lymph nodes on the same or opposite side of the chest. Substage, tumour biology and whether the cancer can be removed safely all affect the plan. A hoarse voice, cough or breathlessness may occur, but none of these symptoms alone identifies the stage or cause.

Doctors may use chest imaging, brain imaging, tissue sampling and lymph-node assessment to map the disease. Genomic tumour profiling can identify features that may influence systemic treatment choices.

A multidisciplinary team may combine chemotherapy, radiotherapy and immunotherapy, or recommend surgery for carefully selected cases. The sequence depends on tumour type, exact lymph-node locations, breathing reserve and response to initial treatment. A lung lobectomy is one form of surgery, but it is not suitable for every stage three tumour.

Take a written list of medicines and symptoms to appointments. Ask how each treatment affects breathing, swallowing, energy and work or family responsibilities. Supportive care can help manage breathlessness, pain, appetite or anxiety alongside cancer-directed treatment; palliative care can be introduced whenever symptom relief is needed.

Contact your oncology team quickly for new or worsening breathlessness, coughing blood, fever during treatment, chest pain, difficulty swallowing or a rapidly changing hoarse voice. Seek emergency help for severe breathing difficulty, confusion, collapse or chest pain that is sudden or persistent. Do not wait for a routine scan when these symptoms appear.

Which stage three substage applies to me? Where are the involved lymph nodes? Is the disease considered removable? What sequence of treatments do you recommend? Would genomic tumour profiling change the options? How will side effects and response be monitored?